MedTrace Logo

Cholesterol Lowering Effect of Cardio-Complement, an Ayurveda Formulation

NCT04974853 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2021-07-23

No results posted yet for this study

Summary

The aim of this feasibility study was to assess the lipid-lowering effects and safety of a Ayurveda formulation containing Terminalia Arjuna, Withania Sominifera, Garcinia Cambogia and piperine (as bioenhancer)

Conditions

Interventions

COMBINATION_PRODUCT

Cardio-complement

Ayurvedic combination of Terminalia Arjuna, Withania Sominifera, Garcinia Cambogia and piperine (as bioenhancer) in pre-specified dosage.

Sponsors & Collaborators

  • Aarogyam UK

    collaborator OTHER

  • NMP Medical Research Institute

    lead OTHER

Principal Investigators

  • Prashanna T Chockalingam · NMP Medical Research Institute, India

  • Abhijit Venu · Aarogyam UK

  • Skanthesh Lakshmanan · NMP Medical Research Institute, India

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-06-01
Primary Completion
2021-06-30
Completion
2021-07-05

Countries

  • India

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04974853 on ClinicalTrials.gov